Amrize Ltd $AMRZ Stock Bought by Narwhal Capital Management

Narwhal Capital Management boosted its holdings in Amrize Ltd (NYSE:AMRZ) by 23.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 81,263 shares of the company’s stock after purchasing an additional 15,618 shares during the quarter. Narwhal Capital Management’s holdings in Amrize were worth $3,038,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. DMKC Advisory Services LLC grew its stake in Amrize by 11.3% during the third quarter. DMKC Advisory Services LLC now owns 75,488 shares of the company’s stock worth $2,823,000 after buying an additional 7,656 shares in the last quarter. Pictet Asset Management Holding SA increased its holdings in Amrize by 4.3% in the 3rd quarter. Pictet Asset Management Holding SA now owns 6,126,150 shares of the company’s stock valued at $230,110,000 after buying an additional 253,512 shares during the period. CenterBook Partners LP raised its position in shares of Amrize by 1,123.6% in the 3rd quarter. CenterBook Partners LP now owns 101,408 shares of the company’s stock valued at $3,792,000 after buying an additional 93,120 shares in the last quarter. Kestra Advisory Services LLC raised its position in shares of Amrize by 12.7% in the 3rd quarter. Kestra Advisory Services LLC now owns 165,401 shares of the company’s stock valued at $6,184,000 after buying an additional 18,637 shares in the last quarter. Finally, Rakuten Investment Management Inc. acquired a new position in shares of Amrize in the 3rd quarter valued at approximately $1,220,000.

Analysts Set New Price Targets

A number of brokerages recently issued reports on AMRZ. William Blair set a $40.00 price objective on shares of Amrize in a research note on Wednesday, September 2nd. Berenberg Bank downgraded shares of Amrize from a “buy” rating to a “hold” rating and lowered their price objective for the company from $48.00 to $46.00 in a research report on Monday. JPMorgan Chase & Co. cut their target price on Amrize from $52.00 to $48.00 and set a “neutral” rating for the company in a research note on Tuesday, October 13th. Weiss Ratings downgraded Amrize from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, October 8th. Finally, Oppenheimer reduced their target price on Amrize from $55.00 to $52.00 and set an “outperform” rating on the stock in a report on Monday, November 2nd. Eight equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $47.65.

Insider Transactions at Amrize

In other Amrize news, Director Jacques Sanche bought 4,150 shares of the firm’s stock in a transaction that occurred on Wednesday, August 26th. The stock was acquired at an average price of $45.02 per share, with a total value of $186,833.00. Following the completion of the purchase, the director directly owned 9,766 shares of the company’s stock, valued at approximately $439,665.32. This trade represents a 73.90% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Jan Jenisch acquired 4,000 shares of Amrize stock in a transaction dated Wednesday, September 2nd. The shares were bought at an average cost of $42.50 per share, with a total value of $170,000.00. Following the transaction, the chief executive officer owned 519,000 shares in the company, valued at approximately $22,057,500. This trade represents a 0.78% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last quarter, insiders have acquired 34,155 shares of company stock valued at $1,461,276. Company insiders own 0.54% of the company’s stock.

Amrize Trading Down 2.0%

Shares of NYSE AMRZ opened at $41.96 on Wednesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.67 and a current ratio of 1.07. Amrize Ltd has a 52-week low of $35.78 and a 52-week high of $65.94. The firm has a 50 day moving average price of $39.46 and a two-hundred day moving average price of $50.18. The stock has a market cap of $23.21 billion, a P/E ratio of 18.99, a price-to-earnings-growth ratio of 1.68 and a beta of 0.04.

Amrize (NYSE:AMRZ) last posted its quarterly earnings data on Wednesday, October 28th. The company reported $1.05 EPS for the quarter, hitting analysts’ consensus estimates of $1.05. Amrize had a return on equity of 10.02% and a net margin of 9.93%. The company had revenue of $3.77 billion for the quarter. During the same period in the prior year, the firm earned $0.98 earnings per share. Amrize’s revenue was up 2.6% compared to the same quarter last year. As a group, equities analysts forecast that Amrize Ltd will post 2.30 EPS for the current year.

Amrize Announces Dividend

The firm also recently declared a dividend, which will be paid on Wednesday, November 18th. Shareholders of record on Tuesday, November 10th will be issued a dividend of $0.11 per share. The ex-dividend date is Tuesday, November 10th. Amrize’s dividend payout ratio (DPR) is presently 4.98%.

Amrize Profile

Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets. The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects. Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim’s North American business.